Chunhong He

882 total citations
21 papers, 278 citations indexed

About

Chunhong He is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chunhong He has authored 21 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Chunhong He's work include Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Acute Myeloid Leukemia Research (2 papers). Chunhong He is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Acute Myeloid Leukemia Research (2 papers). Chunhong He collaborates with scholars based in United States, China and Canada. Chunhong He's co-authors include Peggy Scherle, Wenqing Yao, Jin‐Cong Zhuo, Richard Wynn, Gengjie Yang, Qian Wang, Cindy Marando, Holly K. Koblish, Meizhong Xu and Xiangdong Liu and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Chunhong He

16 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunhong He United States 6 138 98 86 74 40 21 278
Tracy Lou United States 3 209 1.5× 115 1.2× 90 1.0× 57 0.8× 65 1.6× 3 334
Hui Qin Wang United States 5 153 1.1× 41 0.4× 119 1.4× 69 0.9× 27 0.7× 12 297
Keerthi Kurma France 9 122 0.9× 78 0.8× 99 1.2× 40 0.5× 38 0.9× 17 302
Haigang Geng China 7 140 1.0× 57 0.6× 72 0.8× 75 1.0× 22 0.6× 20 311
Yunwei Han China 8 71 0.5× 34 0.3× 61 0.7× 44 0.6× 19 0.5× 16 225
Setsuo Funasaka Japan 8 161 1.2× 58 0.6× 104 1.2× 52 0.7× 29 0.7× 19 297
Chiara Modica Italy 10 122 0.9× 53 0.5× 104 1.2× 31 0.4× 19 0.5× 22 227
Colan Ho-Yen United Kingdom 7 122 0.9× 39 0.4× 138 1.6× 43 0.6× 32 0.8× 12 288
Haojiang Dai China 7 207 1.5× 37 0.4× 72 0.8× 47 0.6× 30 0.8× 9 315
Peiqin Wang China 7 187 1.4× 54 0.6× 66 0.8× 29 0.4× 20 0.5× 14 332

Countries citing papers authored by Chunhong He

Since Specialization
Citations

This map shows the geographic impact of Chunhong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunhong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunhong He more than expected).

Fields of papers citing papers by Chunhong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunhong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunhong He. The network helps show where Chunhong He may publish in the future.

Co-authorship network of co-authors of Chunhong He

This figure shows the co-authorship network connecting the top 25 collaborators of Chunhong He. A scholar is included among the top collaborators of Chunhong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunhong He. Chunhong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ye, Xin Lv, Fufeng Wang, et al.. (2025). Predictive and prognostic value of genetic aberrations of EGFR-TKI treatment: a real-world analysis of EGFR-mutant non-small cell lung cancer. Journal of Thoracic Disease. 17(10). 8978–8991.
2.
3.
He, Chunhong, et al.. (2024). Traffic Scene Object Detection Based on YOLO Algorithm. 314–318.
4.
He, Chunhong, et al.. (2023). Design of Online Intelligent Detection System for Power Quality and Fault Identification in Distribution Networks. Applied Mathematics and Nonlinear Sciences. 9(1). 1 indexed citations
5.
Burns, David, Chunhong He, Yunlong Li, et al.. (2022). Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1. Bioorganic & Medicinal Chemistry Letters. 73. 128884–128884. 1 indexed citations
6.
He, Zewei, Bin Ren, & Chunhong He. (2022). Identification of influencing factors of urban traffic congestion based on ordered Logistic regression. 2022 7th International Conference on Intelligent Computing and Signal Processing (ICSP). 32. 914–918. 1 indexed citations
7.
Diamond, Melody, Chunhong He, Liangxing Wu, et al.. (2021). Abstract 1134: The LSD1 inhibitor INCB059872 is a possible therapeutic option for venetoclax-resistant AML. Cancer Research. 81(13_Supplement). 1134–1134. 1 indexed citations
8.
9.
Ye, Min, Melody Diamond, Michaël Weber, et al.. (2018). Abstract 1888: The FAD-directed LSD1 specific inhibitor, INCB059872, is a promising epigenetic agent for AML therapy by inducing differentiation of leukemic stem/progenitor cells. Cancer Research. 78(13_Supplement). 1888–1888. 4 indexed citations
10.
Lee, Sang‐Hyun, Melody Diamond, Alla Volgina, et al.. (2018). Abstract 3929: The FAD-directed LSD1 specific inhibitor, INCB059872, inhibits cell migration and metastasis by suppressing premetastatic niche formation in a spontaneous metastasis mouse model. Cancer Research. 78(13_Supplement). 3929–3929. 4 indexed citations
11.
Ye, Min, Huiqing Liu, Melody Diamond, et al.. (2017). Abstract 1162: The evaluation of INCB059872, an FAD-directed covalent inhibitor of LSD1, in preclinical models of Ewing sarcoma. Cancer Research. 77(13_Supplement). 1162–1162. 1 indexed citations
12.
Condamine, Thomas, Steve Wang, Melody Diamond, et al.. (2017). Abstract 4635: The LSD1 Specific Inhibitor INCB059872 enhances the activity of immune checkpoint blockade by reshaping the myeloid compartment in the syngeneic 4T1 mouse mammary tumor model. Cancer Research. 77(13_Supplement). 4635–4635. 3 indexed citations
13.
Lee, Sang‐Hyun, Melody Diamond, Margaret Favata, et al.. (2016). Abstract 4704: The evaluation of INCB059872, an FAD-directed inhibitor of LSD1, in preclinical models of human small cell lung cancer. Cancer Research. 76(14_Supplement). 4704–4704. 15 indexed citations
14.
He, Chunhong, et al.. (2016). Peripheral Nerve Injuries Following Cardiac Surgery: A Neglected Side Effect. Scholars Journal of Applied Medical Sciences. 4(6). 2229–2233.
15.
Liu, Xuesong, Matthew C. Stubbs, Min Ye, et al.. (2016). Abstract 4702: Combination of BET inhibitor INCB054329 and LSD1 inhibitor INCB059872 is synergistic for the treatment of AML in vitro and in vivo. Cancer Research. 76(14_Supplement). 4702–4702. 6 indexed citations
16.
Liu, Xiangdong, Qian Wang, Gengjie Yang, et al.. (2011). A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3. Clinical Cancer Research. 17(22). 7127–7138. 190 indexed citations
17.
Burns, David, Yunlong Li, Yunlong Li, et al.. (2009). Compelling P1 substituent affect on metalloprotease binding profile enables the design of a novel cyclohexyl core scaffold with excellent MMP selectivity and HER-2 sheddase inhibition. Bioorganic & Medicinal Chemistry Letters. 19(13). 3525–3530. 4 indexed citations
18.
Burns, David, Chunhong He, Yanlong Li, et al.. (2007). Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle P1′ permutations. Bioorganic & Medicinal Chemistry Letters. 18(2). 560–564. 13 indexed citations
19.
Zhuo, Jin‐Cong, Wenqing Yao, David Burns, et al.. (2007). Asymmetric Synthesis of Conformationally Constrained trans-2,3-Piperidinedicarboxylic Acid Derivatives. Synlett. 2007(3). 460–464. 9 indexed citations
20.
He, Chunhong, et al.. (2004). Static transfer switch (STS) model in EMTPWorks RV. 111–116. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracy Lou Breakdown of academic impact, for papers by Hui Qin Wang Breakdown of academic impact, for papers by Keerthi Kurma Breakdown of academic impact, for papers by Haigang Geng Breakdown of academic impact, for papers by Yunwei Han Breakdown of academic impact, for papers by Setsuo Funasaka Breakdown of academic impact, for papers by Chiara Modica Breakdown of academic impact, for papers by Colan Ho-Yen Breakdown of academic impact, for papers by Haojiang Dai Breakdown of academic impact, for papers by Peiqin Wang
Rankless by CCL
2026